An anti-oxidizing agent or skin stress suppressing agent was provided with.

An anti-oxidizing agent or skin stress suppressing agent comprising a wavelength conversion substance as an active ingredient; a composition and a product comprising the anti-oxidizing agent or skin stress suppressing agent; and a method for suppressing oxidization and skin stress of skin using thereof were provided with. The present invention can exhibit a desirable effect on skin by effectively making use of ultraviolet light to suppress skin cells.

Four dimensional (4D) energy-field package assembly for projecting energy fields according to a 4D coordinate function. The 4D energy-field package assembly includes an energy-source system having energy sources capable of providing energy to energy locations, and energy waveguides for directing energy from the energy locations from one side of the energy waveguide to another side of the energy waveguide along energy propagation paths.

A phototherapy treatment apparatus and methods are provided. In particular, the present disclosure provides a phototherapy treatment apparatus configured to diffusely transmit light emitted from a light source to a patient.

A skin care device can include a body including a battery and a grip electrode electrically connected to the battery, and a head connected to one end of the body. The head includes a contact electrode electrically connected to the battery and configured to come in contact with a skin of a user, and at least one ultraviolet light source disposed inside the head to face the contact electrode. Further, the contact electrode includes a fastening part fastened to the head and having at least one hole formed therein to correspond to the at least one ultraviolet light source, and a plurality of contact protrusions protruding from a top surface of the fastening part.

A hand sanitization system, a sanitization machine, and hand coverings containing markings for use with the sanitization machine are disclosed. The hand sanitization machine is capable of sanitizing hand coverings that were traditionally disposed of after one use. The hand coverings may contain indicators that signal when they have been sterilized.

Devices and related methods for impinging light on tissue to induce one or more biological effects, and more particularly illumination devices and related methods for phototherapeutic light treatments in the presence of vitamins are disclosed. Biological effects may include at least one of inactivating and inhibiting growth of one or more combinations of microorganisms and pathogens, including but not limited to viruses. Phototherapeutic light treatments in the presence of vitamins may involve providing one or more vitamins in the form of a coating or film on a surface of a target tissue and irradiating the target tissue with light. By performing the phototherapeutic light treatment in the presence of vitamins, efficacy of the light treatment may be improved, thereby reducing viral loads and/or reducing doses of light received by the target tissue.

Certain exemplary embodiments can provide an apparatus and method for generating at least one radiation. The exemplary apparatus and/or method can selectively kill and/or affect at least one bacteria. For example, a radiation source first arrangement can be provided which is configured to generate at least one radiation having one or more wavelengths provided in a range of about 190 nanometers (nm) to about 230 nm, and at least one second arrangement can be provided which is configured to prevent the at least one radiation from having any wavelength that is outside of the range.

The invention relates to a method for the production of milk with a high content of native vitamin D3, comprising the irradiation of one or more lactating animals in a roofed enclosure, having at least one luminaire with a lamp emitting UV-A and UV-B radiation, and the milking of animals. The method allows producing milk having a high content of native vitamin D. The method also leads to an improved milk yield per animal.

The present invention relates to a therapy for vitiligo. In particular the present invention provides a pharmaceutical composition comprising an alpha melanocyte stimulating hormone (alpha-MSH) analogue either alone, in combination with narrow band UVB and/or in combination with one or more corticosteroids, immunosuppressants, anti-inflammatory agents and/or photochemotherapeutic agents for the treatment or prevention of vitiligo.

The invention relates generally to a formulation in which metal tungstate or metal molybdate particles are encapsulated within biocompatible, diseased cell-targeting polymeric coatings. Such formulations render metal tungstate or metal molybdate particles suitable for in vivo biomedical imaging and therapeutic applications.